Expression of cyclooxygenase-2, glucose transporter-1 and angiogenesis in gallbladder carcinomas and their impact on prognosis

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Scandinavian Journal of Gastroenterology

• Publication date

  2009-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/00365520903121685PMID 19606394
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The utility of GLUT‐1 immunolocalization in cell blocks

  2006cited by this paper
• GLUT-1 is Preferentially Expressed in Atypical Endometrial Hyperplasia and Endometrial Adenocarcinoma

  2006cited by this paper
• Expression of cyclooxygenase-2 is associated with p53 accumulation in premalignant and malignant gallbladder lesions.

  2006cited by this paper
• Cyclooxygenase-2 promotes angiogenesis by increasing vascular endothelial growth factor and predicts prognosis in gallbladder carcinoma.

  2005cited by this paper
• Clinicopathological and prognostic implications of endoglin (CD105) expression in hepatocellular carcinoma and its adjacent non-tumorous liver.

  2005cited by this paper
• Prognostic relevance of CD105+ microvessel density in HNSCC patient outcome.

  2005cited by this paper
• Coexpression of cyclooxygenases (COX-1, COX-2) and vascular endothelial growth factors (VEGF-A, VEGF-C) in esophageal adenocarcinoma.

  2005cited by this paper
• Is the hypoxia-inducible factor pathway important in gastric cancer?

  2005cited by this paper
• Comparative analysis of COX‐2, vascular endothelial growth factor and microvessel density in human renal cell carcinomas

  2004cited by this paper
• Overexpression of cyclooxygenase-2 and tumor angiogenesis in human gastric cancer.

  2004cited by this paper
• COX-2 expression correlates with microvessel density in non-melanoma skin cancer from renal transplant recipients and immunocompetent individuals.

  2004cited by this paper
• Prognostic impact of hypoxia-inducible factors 1alpha and 2alpha in colorectal cancer patients: correlation with tumor angiogenesis and cyclooxygenase-2 expression.

  2004cited by this paper
• The Contributions of Cyclooxygenase-2 to Tumor Angiogenesis

  2004cited by this paper
• Factors influencing recurrence after surgical treatment for T2 gallbladder carcinoma.

  2004cited by this paper
• Prognostic Impact of Hypoxia-Inducible Factors 1α and 2α in Colorectal Cancer Patients

  2004cited by this paper
• Cyclooxygenase 2: a molecular target for cancer prevention and treatment.

  2003cited by this paper
• Angiogenesis: Tumorigenesis and the angiogenic switch

  2003cited by this paper
• Vascular endothelial growth factor-C expression in human gallbladder cancer and its relationship to lymph node metastasis.

  2003cited by this paper
• Glucose transporter-1 (GLUT-1): a potential marker of prognosis in rectal carcinoma?

  2003cited by this paper
• Emerging role of endoglin (CD105) as a marker of angiogenesis with clinical potential in human malignancies.

  2003cited by this paper
• Role of cyclooxygenase-2 in the angiogenesis of colorectal cancer

  2003cited by this paper
• Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis

  2003cited by this paper
• Expression of the GLUT1 glucose transporter in gallbladder carcinomas.

  2002cited by this paper
• Prognostic significance of cyclooxygenase-2 pathway and angiogenesis in head and neck squamous cell carcinoma.

  2002cited by this paper
• Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo.

  2002cited by this paper
• Prognostic significance of p53, Ki-67, VEGF and Glut-1 in resected stage I adenocarcinoma of the lung.

  2002cited by this paper
• Prognostic Role of Angiogenesis in Operable Carcinoma of the Gallbladder

  2002cited by this paper
• Assessment of Glut-1 expression in cholangiocarcinoma, benign biliary lesions and hepatocellular carcinoma.

  2002cited by this paper
• Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis.

  2001cited by this paper
• Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix.

  2001cited by this paper
• Clinical Significance of Human Erythrocyte Glucose Transporter 1 Expression at the Deepest Invasive Site of Advanced Colorectal Carcinoma

  2001cited by this paper
• Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody.

  2001cited by this paper
• The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis.

  2000cited by this paper
• Tumor angiogenesis in gallbladder carcinoma.

  1999cited by this paper
• Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis.

  1999cited by this paper
• Survival of patients with primary liver cancer, pancreatic cancer and biliary tract cancer in Europe. EUROCARE Working Group.

  1998cited by this paper
• GLUT1 glucose transporter expression in colorectal carcinoma

  1998cited by this paper
• Tumour hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix.

  1998cited by this paper
• Expression of vascular endothelial growth factor correlates with tumor progression in gallbladder cancer.

  1998cited by this paper
• Dual Control of glut1 Glucose Transporter Gene Expression by Hypoxia and by Inhibition of Oxidative Phosphorylation*

  1997cited by this paper
• Intratumor microvessel density as a prognostic factor in cancer.

  1995cited by this paper
• Hypoxia and Mitochondrial Inhibitors Regulate Expression of Glucose Transporter-1 via Distinct Cis-acting Sequences (*)

  1995cited by this paper
• Differential Activation of the Rat Phenylethanolamine N-Methyltransferase Gene by Sp1 and Egr-1 (*)

  1995cited by this paper
• Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas.

  1994cited by this paper

• Glucose-transporter 1 (GLUT1) as a prognostic biomarker: evidence from 14,966 human tumors across 134 cancer types

  2026cites this paper
• Plumbagin-mediating GLUT1 suppresses the growth of human tongue squamous cell carcinoma.

  2018cites this paper
• Glucose transporter-1 as an independent prognostic marker for cancer: a meta-analysis

  2017cites this paper
• The prognostic value of GLUT1 in cancers: a systematic review and meta-analysis

  2017cites this paper
• Adenocarcinoma of the Gallbladder: Risk Factors and Pathogenic Pathways

  2016cites this paper
• Prognostic molecular markers in resected extrahepatic biliary tract cancers; a systematic review and meta-analysis of immunohistochemically detected biomarkers.

  2015cites this paper
• Metabolic phenotypes in primary unknown metastatic carcinoma

  2014cites this paper
• EVALUATION OF P53, E-CADHERIN, COX-2, AND EGFR PROTEIN IMUNNOEXPRESSION ON PROGNOSTIC OF RESECTED GALLBLADDER CARCINOMA

  2014cites this paper
• Effect on the expression of MMP-2, MT-MMP in laryngeal carcinoma Hep-2 cell line by antisense glucose transporter-1.

  2012cites this paper
• Hypoxia-related protein expression and its clinicopathologic implication in carcinoma of unknown primary

  2011cites this paper
• Glucose Transporter-1 (GLUT-1) Immunoreactivity in Benign, Premalignant and Malignant Lesions of the Gallbladder

  2011cites this paper
• Glucose Transporter-1 as a New Therapeutic Target in Laryngeal Carcinoma

  2010cites this paper
• The application of metabolic network analysis in understanding and targeting metabolism for drug discovery

  2010cites this paper
• Cyclooxygenase-2, p53 and glucose transporter-1 as predictors of malignancy in the development of gallbladder carcinomas.

  2010cites this paper
• This month in Scandinavian Journal of Gastroenterology

  2009cites this paper
• Prognostic Correlation of the expression of Glucose Transporter with Positron Emission Tomography in Gallbladder cancer

  2008influential citation